178 related articles for article (PubMed ID: 31562178)
41. Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin.
Villani C; Sacchetti G; Carli M; Invernizzi RW
Neuropharmacology; 2020 Oct; 176():108221. PubMed ID: 32652084
[TBL] [Abstract][Full Text] [Related]
42. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.
Giacometti E; Luikenhuis S; Beard C; Jaenisch R
Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1931-6. PubMed ID: 17267601
[TBL] [Abstract][Full Text] [Related]
43. Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model.
Viola A; Saywell V; Villard L; Cozzone PJ; Lutz NW
PLoS One; 2007 Jan; 2(1):e157. PubMed ID: 17237885
[TBL] [Abstract][Full Text] [Related]
44. Pharmacological reactivation of inactive X-linked
Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
[TBL] [Abstract][Full Text] [Related]
45. EEA1 restores homeostatic synaptic plasticity in hippocampal neurons from Rett syndrome mice.
Xu X; Pozzo-Miller L
J Physiol; 2017 Aug; 595(16):5699-5712. PubMed ID: 28621434
[TBL] [Abstract][Full Text] [Related]
46. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
47. Optimized Administration of the M
Cikowski J; Holt C; Arthur B; Smith M; Gonzalez S; Lindsley CW; Niswender CM; Gogliotti RG
ACS Chem Neurosci; 2022 Jul; 13(13):1891-1901. PubMed ID: 35671352
[TBL] [Abstract][Full Text] [Related]
48. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.
Asaka Y; Jugloff DG; Zhang L; Eubanks JH; Fitzsimonds RM
Neurobiol Dis; 2006 Jan; 21(1):217-27. PubMed ID: 16087343
[TBL] [Abstract][Full Text] [Related]
49. Metabolomic Fingerprint of Mecp2-Deficient Mouse Cortex: Evidence for a Pronounced Multi-Facetted Metabolic Component in Rett Syndrome.
Golubiani G; Lagani V; Solomonia R; Müller M
Cells; 2021 Sep; 10(9):. PubMed ID: 34572143
[TBL] [Abstract][Full Text] [Related]
50. Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome.
Matagne V; Borloz E; Ehinger Y; Saidi L; Villard L; Roux JC
Neurobiol Dis; 2021 Feb; 149():105235. PubMed ID: 33383186
[TBL] [Abstract][Full Text] [Related]
51. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.
Tsujimura K; Irie K; Nakashima H; Egashira Y; Fukao Y; Fujiwara M; Itoh M; Uesaka M; Imamura T; Nakahata Y; Yamashita Y; Abe T; Takamori S; Nakashima K
Cell Rep; 2015 Sep; 12(11):1887-901. PubMed ID: 26344767
[TBL] [Abstract][Full Text] [Related]
52. Intrinsic membrane properties of locus coeruleus neurons in Mecp2-null mice.
Zhang X; Cui N; Wu Z; Su J; Tadepalli JS; Sekizar S; Jiang C
Am J Physiol Cell Physiol; 2010 Mar; 298(3):C635-46. PubMed ID: 20042730
[TBL] [Abstract][Full Text] [Related]
53. The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis.
Forlani G; Giarda E; Ala U; Di Cunto F; Salani M; Tupler R; Kilstrup-Nielsen C; Landsberger N
Hum Mol Genet; 2010 Aug; 19(16):3114-23. PubMed ID: 20504995
[TBL] [Abstract][Full Text] [Related]
54. Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome.
Ehinger Y; Matagne V; Cunin V; Borloz E; Seve M; Bourgoin-Voillard S; Borges-Correia A; Villard L; Roux JC
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919253
[TBL] [Abstract][Full Text] [Related]
55. MeCP2 links heterochromatin condensates and neurodevelopmental disease.
Li CH; Coffey EL; Dall'Agnese A; Hannett NM; Tang X; Henninger JE; Platt JM; Oksuz O; Zamudio AV; Afeyan LK; Schuijers J; Liu XS; Markoulaki S; Lungjangwa T; LeRoy G; Svoboda DS; Wogram E; Lee TI; Jaenisch R; Young RA
Nature; 2020 Oct; 586(7829):440-444. PubMed ID: 32698189
[TBL] [Abstract][Full Text] [Related]
56. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.
Chao HT; Chen H; Samaco RC; Xue M; Chahrour M; Yoo J; Neul JL; Gong S; Lu HC; Heintz N; Ekker M; Rubenstein JL; Noebels JL; Rosenmund C; Zoghbi HY
Nature; 2010 Nov; 468(7321):263-9. PubMed ID: 21068835
[TBL] [Abstract][Full Text] [Related]
57. Restoration of Mecp2 expression in GABAergic neurons is sufficient to rescue multiple disease features in a mouse model of Rett syndrome.
Ure K; Lu H; Wang W; Ito-Ishida A; Wu Z; He LJ; Sztainberg Y; Chen W; Tang J; Zoghbi HY
Elife; 2016 Jun; 5():. PubMed ID: 27328321
[TBL] [Abstract][Full Text] [Related]
58. MeCP2 loss-of-function dysregulates microRNAs regionally and disrupts excitatory/inhibitory synaptic transmission balance.
Horvath PM; Piazza MK; Kavalali ET; Monteggia LM
Hippocampus; 2022 Aug; 32(8):610-623. PubMed ID: 35851733
[TBL] [Abstract][Full Text] [Related]
59. Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.
Okabe Y; Takahashi T; Mitsumasu C; Kosai K; Tanaka E; Matsuishi T
PLoS One; 2012; 7(4):e35354. PubMed ID: 22532851
[TBL] [Abstract][Full Text] [Related]
60. Stimulation of the Serotonin Receptor 7 Restores Brain Histone H3 Acetylation and MeCP2 Corepressor Protein Levels in a Female Mouse Model of Rett Syndrome.
Napoletani G; Vigli D; Cosentino L; Grieco M; Talamo MC; Lacivita E; Leopoldo M; Laviola G; Fuso A; d'Erme M; De Filippis B
J Neuropathol Exp Neurol; 2021 Feb; 80(3):265-273. PubMed ID: 33598674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
